Document Detail


SP1 in pregnancies with Down syndrome in the first trimester of pregnancy. International Prenatal Screening Research Group.
MedLine Citation:
PMID:  10416965     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We conducted a study to determine the value of serum pregnancy-specific beta-1-glycoprotein (Schwangerschafts protein 1, SP1) as an antenatal screening test for Down syndrome in the first trimester. Serum samples collected from women at 8 to 14 weeks of pregnancy, immediately prior to having a chorionic villus sampling procedure on account of advanced maternal age, were retrieved from 96 women with Down syndrome pregnancies (cases) and from 480 women with unaffected pregnancies (controls). Cases and controls were ascertained at 21 obstetric centres in nine countries. Each case was matched with five controls for maternal age (same five-year age groups), duration of storage of the serum sample (same calendar year) and gestational age (usually the same week of pregnancy). The levels of SP1 were lower in pregnancies associated with Down syndrome: the median level was 0.86 multiples of the median level in the controls (95 per cent confidence interval 0.76 to 0.97). This difference, though statistically significant, was not large enough for SP1 to be a useful marker in screening, at least from 10 weeks onwards where most of our data lie.
Authors:
N J Wald; H C Watt; B Norgaard-Pedersen; M Christiansen
Related Documents :
1768345 - Routine examination by ultrasound for the detection of fetal malformations in a low ris...
18070805 - The clinical utility of screening of biochemical parameters in elite athletes: analysis...
10685985 - Reproductive decisions after neonatal screening identifies cystic fibrosis.
20688785 - Screening and intervention for domestic violence during pregnancy care: a systematic re...
19869125 - Further data on the effect of vaccination against bovine infectious abortion.
8550835 - Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the ro...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  19     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-12-02     Completed Date:  1999-12-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  517-20     Citation Subset:  IM    
Affiliation:
Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's and the Royal London School of Medicine and Dentistry, Charterhouse Square, UK. n.j.wald@mds.qmw.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Case-Control Studies
Down Syndrome / diagnosis*
Female
Humans
Pregnancy
Pregnancy Trimester, First / blood*
Pregnancy-Specific beta 1-Glycoproteins / analysis*
Prenatal Diagnosis / methods*
Regression Analysis
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Pregnancy-Specific beta 1-Glycoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Maternal serum activin A and follistatin levels in pregnancies with Down syndrome.
Next Document:  A comparison of different density gradients and antibodies for enrichment of fetal erythroblasts by ...